BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/7/2014 1:30:00 PM | Browse: 952 | Download: 855
Publication Name World Journal of Gastroenterology
Manuscript ID 6537
Country/Territory Brazil
Received
2013-10-23 12:18
Peer-Review Started
2013-10-24 09:24
To Make the First Decision
2014-02-28 19:27
Return for Revision
2014-03-07 17:53
Revised
2014-03-14 19:13
Second Decision
2014-05-05 08:33
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-05 09:47
Articles in Press
2014-05-23 10:14
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-08-18 17:17
Publish the Manuscript Online
2014-09-07 13:31
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Perspectives on new biomarkers in gastric cancer: Diagnostic and prognostic applications
Manuscript Source Invited Manuscript
All Author List Danilo do Rosário Pinheiro, Wallax Augusto Silva Ferreira, Mariceli Baia Leão Barros, Mariana Diniz Araújo, Symara Rodrigues-Antunes and Bárbara do Nascimento Borges
Funding Agency and Grant Number
Corresponding Author Bárbara do Nascimento Borges, PhD, Center of Agropecuary Technology, Socio-environmental and Hydric Resources Institute, Federal Rural University of Amazonia, Avenida Presidente Tancredo Neves 2501, Belém PA 66077-530, Brazil. barbara.borges@ufra.edu.br
Key Words Molecular markers; Epigenetic; Genetic; Proteomic; Diagnosis; Prognosis; Gastric tumors
Core Tip Despite the advances in technology and its access, to date, there are few defined biomarkers of prognostic and diagnostic use for gastric tumors. Therefore, a combination of several approaches (genetic, epigenetic and proteomic) should be considered the best alternative for clinical practice. Considering this point of view, this review aims to discuss the most studied biomarkers, discussing the pros and cons of each type of marker and their use in the clinical practice.
Publish Date 2014-09-07 13:31
Citation Pinheiro DR, Ferreira WAS, Barros MBL, Araújo MD, Rodrigues-Antunes S, Borges BN. Perspectives on new biomarkers in gastric cancer: Diagnostic and prognostic applications. World J Gastroenterol 2014; 20(33): 11574-11585
URL http://www.wjgnet.com/1007-9327/full/v20/i33/11574.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i33.11574
Full Article (PDF) WJG-20-11574.pdf
Full Article (Word) WJG-20-11574.doc
Manuscript File 6537-Review.doc
Answering Reviewers 6537-Answering reviewers.pdf
Copyright License Agreement 6537-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 6537-Language certificate.pdf
Peer-review Report 6537-Peer review(s).pdf
Scientific Editor Work List 6537-Scientific editor work list.pdf